drugset / Trial / NCT03974516
Careseng 1370 for Healthy Volunteers
Non-randomizedSequentialOpen-labelTreatment
Summary
This study will be performed in healthy volunteers in a conventional 3+3 dose-escalation design.
Timeline
- Start
- 2020-08-10
- Primary completion
- 2022-03-11
- Completion
- 2022-03-11
Outcome
Outcome not reported
Stopped (Enrollment): “This study was early terminated by the sponsor considering the difficulty of subject recruitment in the pandemic of COVID-19.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Careseng 1370 | Unknown | 4000 mg | Oral |
| Subject | Careseng 1370 | Unknown | 8000 mg | Oral |
| Subject | Careseng 1370 | Unknown | 12000 mg | Oral |